NCT05764525View on ClinicalTrials.gov

Efficacy and Safety of VVZ-149 Injections in Patients Undergoing Laparoscopic Colectomy

PHASE3CompletedINTERVENTIONAL
Enrollment

285

Participants

Timeline

Start Date

July 19, 2021

Primary Completion Date

November 3, 2022

Study Completion Date

November 22, 2022

Conditions
Pain, PostoperativeAcute Pain
Interventions
DRUG

VVZ-149 Injections

IV infusion of 1000 mg of VVZ-149

DRUG

Placebo

IV infusion of 0 mg of VVZ-149

Trial Locations (5)

Unknown

Asan Medical Center, Seoul

Korea University Anam Hospital, Seoul

Samsung Medical Center, Seoul

Seoul National University Bundang Hospital, Seoul

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Vivozon Pharmaceutical Inc.

INDUSTRY

NCT05764525 - Efficacy and Safety of VVZ-149 Injections in Patients Undergoing Laparoscopic Colectomy | Biotech Hunter | Biotech Hunter